UCB SA (UCBb)

BATS Europe


	Symbol		Exchange		Currency
	UCB		Brussels		EUR	Real-time
	UCBb		BATS Europe		EUR	Delayed
	UCBJY		OTC Markets		USD	Delayed
	0NZT		London		EUR	Real-time
	UCB		TradeGate		EUR	Delayed
	UCB		Frankfurt		EUR	Delayed
	UCB		Vienna		EUR	Real-time

Currency in EUR

Disclaimer

170.58

+1.63(+0.96%)

Closed11/10

Fair Value

Day's Range

168.35

170.85

52 wk Range

65.61

170.85

UCBb Income Statement

Featured here, the Income Statement (earnings report) for UCB SA, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

4,913

5,347

5,777

5,447

5,182

Total Revenues Growth

+6.07%

+8.83%

+8.04%

-5.71%

-4.87%

Cost Of Revenues

1,268

1,363

1,438

1,674

1,707

Gross Profit

3,645

3,984

4,339

3,773

3,475

Gross Profit Growth

+6.14%

+9.3%

+8.91%

-13.04%

-7.9%

Gross Profit Margin %

74.19%

74.51%

75.11%

69.27%

67.06%

Other Operating Expenses, Total

2,534

2,948

3,025

3,174

2,897

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+9.13%	+16.34%	+2.61%	+4.93%	-8.73%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1,272	1,569	1,629	1,670	1,630
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1,303	1,417	1,554	1,714	1,824
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-41	-38	-158	-210	-557

Operating Income

1,111

1,036

1,314

599

578

Operating Income Growth

-0.09%

-6.75%

+26.83%

-54.41%

-3.51%

EBIT Margin %

22.61%

19.38%

22.75%

11%

11.15%

Net Interest Expenses

-43

-54

-36

-60

-114

Net Interest Expenses Growth

+6.52%

-25.58%

+33.33%

-66.67%

-90%

Interest Expense, Total

-60

-68

-45

-72

-144

Interest And Investment Income

17

14

9

12

30

Other Non Operating Expenses, Total

-64

-37

-23

-12

-49

EBT, Excl. Unusual Items

1,004

945

1,255

527

415

Gain (Loss) On Sale Of Assets

48

50

-3

71

-26

Other Unusual Items, Total

-44

-

-6

-4

65

EBT, Incl. Unusual Items

961

880

1,225

511

441

EBT, Incl. Unusual Items Growth

-5.32%

-8.43%

+39.2%

-58.29%

-13.7%

EBT, Incl. Unusual Items Margin

19.56%

16.46%

21.2%

9.38%

8.51%

Income Tax Expense

146

119

170

91

98

Net Income to Company

817

761

1,058

418

343

Minority Interest

-25

-29

-

-

-

Net Income

792

732

1,058

418

343

Net Income Growth

-1%

-7.58%

+44.54%

-60.49%

-17.94%

Net Income Margin %

16.12%

13.69%

18.31%

7.67%

6.62%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

790

732

1,055

420

343

Basic EPS - Continuing Operations

4.22

3.87

5.58

2.21

1.81

Basic EPS - Continuing Operations Growth

+0.42%

-8.23%

+44.17%

-60.33%

-18.36%

Diluted EPS - Continuing Operations

4.09

3.77

5.44

2.15

1.76

Diluted EPS - Continuing Operations Growth

-2.62%

-7.82%

+44.3%

-60.48%

-18.14%

Basic Weighted Average Shares Outstanding

187.22

189.04

188.97

189.62

189.69

Diluted Weighted Average Shares Outstanding

192.95

194.25

194.18

194.83

195.19

Dividend Per Share

1.24

1.27

1.3

1.33

1.36

Dividend Per Share Growth

+2.48%

+2.42%

+2.36%

+2.31%

+2.26%

EBITDA

1,380

1,342

1,593

1,138

1,269

EBITDA Growth

-1.43%

-2.75%

+18.7%

-28.56%

+11.51%

EBITDA Margin %

28.09%

25.1%

27.57%

20.89%

24.49%

EBIT